Core Med Tech Development ApS: Financial statements 2023
CVR: 37703788
Source: annual report 2023, Danish Business Authority
01/05/2022 – 30/04/2023
Core Med Tech Development ApS (CVR 37703788) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -31,662 and a net result of DKK 1,222,609 compared with DKK -4,340,711 the year before. Equity in the 2023 report amounted to DKK 15,960,654. The solvency ratio was 95.3%.
- Gross Profit
- DKK -31,662
- Profit/Loss
- DKK 1,222,609
- Equity
- DKK 15,960,654
- Total Assets
- DKK 16,755,270
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -32 t. | 1.2 mio. | 16 mio. | - |
| 2022 | - | -13 t. | -4.3 mio. | 16.7 mio. | - |
| 2021 | - | -1.8 mio. | 36 mio. | 27.1 mio. | - |
| 2020 | - | -52 t. | 1.9 mio. | 16.1 mio. | - |
| 2019 | - | -8 t. | 7.2 mio. | 15.2 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of October 1, 2023, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Core Med Tech Development ApS.
As of October 1, 2023, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has stepped down as auditor of Core Med Tech Development ApS.
About Core Med Tech Development ApS
Core Med Tech Development ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Christian Schärfe Baltzer-Thomsen and Steffen Vogel. The company is owned by SASSER G HOLDING ApS and Baltho Holding ApS. In 2025, the company reported a gross profit of DKK -220,933 and a net result of DKK -99,037 compared with DKK 1,645,725 the year before. Equity in the 2025 report amounted to DKK 15,007,343.